Epitope Mapping Orients Immune Interventions
Before Launching an Immune Intervention, Get the Lay of the Land
The Scoop: Tissue Engineering Covers Wide Range of Applications
3D Approach Aims to Replace Human Tissue and Organs
Commercializing Gene Therapies
Using High-Touch Services to Enhance Patient Outcomes
Exosomes from Cancer Cells Could Predict Immunotherapy Responses
Immune-Evasion Mechanism May Help Explain the Differences in Responses to Immunotherapy
For full access to this article login to GEN Select now.
Cellular Models for Finer Screening
- The cost of bringing a new drug to the market has recently been estimated by Forbes Magazine at $5 billion. This figure derives in large part from high attrition rates in the drug development pipeline that arise from failures in drug efficacy or adverse toxic events, such that in ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.